Search Results - "Giordano, Pasqualina"

Evaluation of the Molecular Landscape in PD-L1 Positive Metastatic NSCLC: Data from Campania, Italy by Pisapia, Pasquale, Iaccarino, Antonino, De Luca, Caterina, Acanfora, Gennaro, Bellevicine, Claudio, Bianco, Roberto, Daniele, Bruno, Ciampi, Luisa, De Felice, Marco, Fabozzi, Teresa, Formisano, Luigi, Giordano, Pasqualina, Gridelli, Cesare, Ianniello, Giovanni Pietro, Libroia, Annamaria, Maione, Paolo, Nacchio, Mariantonia, Pagni, Fabio, Palmieri, Giovanna, Pepe, Francesco, Russo, Gianluca, Salatiello, Maria, Santaniello, Antonio, Scamarcio, Rachele, Seminati, Davide, Troia, Michele, Troncone, Giancarlo, Vigliar, Elena, Malapelle, Umberto

“…Background: Immune-checkpoint inhibitors (ICIs) have increased and improved the treatment options for patients with non-oncogene-addicted advanced stage…”
Get full text

Afatinib: An overview of its clinical development in non-small-cell lung cancer and other tumors by Giordano, Pasqualina, Manzo, Anna, Montanino, Agnese, Costanzo, Raffaele, Sandomenico, Claudia, Piccirillo, Maria Carmela, Daniele, Gennaro, Normanno, Nicola, Carillio, Guido, Rocco, Gaetano, Bianco, Roberto, Perrone, Francesco, Morabito, Alessandro

“…Abstract Afatinib is an oral, irreversible, tyrosine kinase inhibitor (TKI) of EGFR, HER2 and HER4. According to phase I studies, the recommended dose of…”
Get full text

Vasari Scoring System in Discerning between Different Degrees of Glioma and IDH Status Prediction: A Possible Machine Learning Application? by Gemini, Laura, Tortora, Mario, Giordano, Pasqualina, Prudente, Maria Evelina, Villa, Alessandro, Vargas, Ottavia, Giugliano, Maria Francesca, Somma, Francesco, Marchello, Giulia, Chiaramonte, Carmela, Gaetano, Marcella, Frio, Federico, Di Giorgio, Eugenio, D'Avino, Alfredo, Tortora, Fabio, D'Agostino, Vincenzo, Negro, Alberto

“…(1) The aim of our study is to evaluate the capacity of the Visually AcceSAble Rembrandt Images (VASARI) scoring system in discerning between the different…”
Get full text

Epigenetic Regulation in Melanoma: Facts and Hopes by Giunta, Emilio Francesco, Arrichiello, Gianluca, Curvietto, Marcello, Pappalardo, Annalisa, Bosso, Davide, Rosanova, Mario, Diana, Anna, Giordano, Pasqualina, Petrillo, Angelica, Federico, Piera, Fabozzi, Teresa, Parola, Sara, Riccio, Vittorio, Mucci, Brigitta, Vanella, Vito, Festino, Lucia, Daniele, Bruno, Ascierto, Paolo Antonio, Ottaviano, Margaret

“…Cutaneous melanoma is a lethal disease, even when diagnosed in advanced stages. Although recent progress in biology and treatment has dramatically improved…”
Get full text

Assessment of therapy response to Regorafenib by 18F-DOPA-PET/CT in patients with recurrent high-grade gliomas: a case series by Di Giorgio, Eugenio, Cuocolo, Alberto, Mansi, Luigi, Sicignano, Marilena, Squame, Fiorenzo, Gaudieri, Valeria, Giordano, Pasqualina, Giugliano, Francesca Maria, Mazzaferro, Maria Pia, Negro, Alberto, Villa, Alessandro, Spadafora, Marco

“…Purpose Regorafenib (REG) has been recently approved for the treatment of relapsed glioblastoma. Contrast-enhanced (CE) magnetic resonance (MR) imaging…”
Get full text

Combining anti-Epidermal Growth Factor Receptor (EGFR) and anti-angiogenic strategies in advanced NSCLC: we should have known better by Di Maio, Massimo, Morabito, Alessandro, Piccirillo, Maria Carmela, Daniele, Gennaro, Giordano, Pasqualina, Costanzo, Raffaele, Sandomenico, Claudia, Montanino, Agnese, Rocco, Gaetano, Perrone, Francesco

“…Drugs directed against Epidermal Growth Factor Receptor (EGFR), namely tyrosine kinase inhibitors erlotinib and gefitinib, and anti-angiogenic agents, namely…”
Get more information

Integrated therapeutic approaches in the treatment of locally advanced non-small cell lung cancer by Di Maio, Massimo, Costanzo, Raffaele, Giordano, Pasqualina, Piccirillo, Maria Carmela, Sandomenico, Claudia, Montanino, Agnese, Carillio, Guido, Muto, Paolo, Jones, David R, Daniele, Gennaro, Perrone, Francesco, Rocco, Gaetano, Morabito, Alessandro

“…Treatment of locally advanced non-small cell lung cancer (NSCLC) remains a significant challenge for oncologists, despite progress made in recent years in…”
Get more information

Time spent for activation of non-profit studies in oncology in Italy by De Feo, Gianfranco, Signoriello, Simona, Bryce, Jane C, Del Giudice, Antonia, Canzanella, Giuliana, Crudele, Federika, Romano, Fiorella, de Matteis, Giovanni, Florio, Manuela, Falasconi, Fabiano, Savio, Alfonso, Giordano, Pasqualina, Daniele, Gennaro, Iaccarino, Mario, Piccirillo, Maria Carmela, Di Maio, Massimo, Morabito, Alessandro, Gallo, Ciro, Perrone, Francesco

“…The aim of this paper is to describe the time spent to activate oncological non-profit clinical trials promoted in Italy by the National Cancer Institute of…”
Get full text

Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Status and Novel Perspectives by Federico, Piera, Petrillo, Angelica, Giordano, Pasqualina, Bosso, Davide, Fabbrocini, Antonietta, Ottaviano, Margaret, Rosanova, Mario, Silvestri, Antonia, Tufo, Andrea, Cozzolino, Antonio, Daniele, Bruno

“…Immune checkpoint inhibitors (ICIs) represent a promising treatment for many kinds of cancers, including hepatocellular carcinoma (HCC). The rationale for…”
Get full text

Progress and challenges in the treatment of small cell lung cancer by Tartarone, Alfredo, Giordano, Pasqualina, Lerose, Rosa, Rodriquenz, Maria Grazia, Conca, Raffaele, Aieta, Michele

“…Small cell lung cancer (SCLC) is a very aggressive malignancy characterized by high cellular proliferation and early metastatic spread. In fact, although SCLC…”
Get full text

Treatment of small cell lung cancer by Morabito, Alessandro, Carillio, Guido, Daniele, Gennaro, Piccirillo, Maria Carmela, Montanino, Agnese, Costanzo, Raffaele, Sandomenico, Claudia, Giordano, Pasqualina, Normanno, Nicola, Perrone, Francesco, Rocco, Gaetano, Di Maio, Massimo

“…Abstract Treatment of small cell lung cancer (SCLC) remains a significant challenge for the oncologists. Attempts to improve the results of first-line…”
Get full text

Case report: Tracing in parallel the salivary and gut microbiota profiles to assist Larotrectinib anticancer treatment for NTRK fusion–positive glioblastoma by Turco, Luigia, Della Monica, Rosa, Giordano, Pasqualina, Cuomo, Mariella, Biazzo, Manuele, Mateu, Baptiste, Di Liello, Raimondo, Daniele, Bruno, Normanno, Nicola, De Luca, Antonella, Rachiglio, Anna Maria, Chiaramonte, Carmela, Giugliano, Francesca Maria, Chiariotti, Lorenzo, Catapano, Giuseppe, Coretti, Lorena, Lembo, Francesca

“…Oncotherapy can shape intestinal microbiota, which, in turn, may influence therapy effectiveness. Furthermore, microbiome signatures during treatments can be…”
Get full text

Early PET/CT scan is more effective than RECIST in predicting outcome of patients with liver metastases from colorectal cancer treated with preoperative chemotherapy plus bevacizumab by Lastoria, Secondo, Piccirillo, Maria Carmela, Caracò, Corradina, Nasti, Guglielmo, Aloj, Luigi, Arrichiello, Cecilia, de Lutio di Castelguidone, Elisabetta, Tatangelo, Fabiana, Ottaiano, Alessandro, Iaffaioli, Rosario Vincenzo, Izzo, Francesco, Romano, Giovanni, Giordano, Pasqualina, Signoriello, Simona, Gallo, Ciro, Perrone, Francesco

“…Markers predictive of treatment effect might be useful to improve the treatment of patients with metastatic solid tumors. Particularly, early changes in tumor…”
Get full text

Randomized phase III trial of gemcitabine and cisplatin vs. gemcitabine alone in patients with advanced non-small cell lung cancer and a performance status of 2: The CAPPA-2 study by Morabito, Alessandro, Gebbia, Vittorio, Di Maio, Massimo, Cinieri, Saverio, Viganò, Maria Grazia, Bianco, Roberto, Barbera, Santi, Cavanna, Luigi, De Marinis, Filippo, Montesarchio, Vincenzo, Costanzo, Raffaele, Sandomenico, Claudia, Montanino, Agnese, Mancuso, Gianfranco, Russo, Paolo, Nacci, Angelo, Giordano, Pasqualina, Daniele, Gennaro, Piccirillo, Maria Carmela, Rocco, Gaetano, Gridelli, Cesare, Gallo, Ciro, Perrone, Francesco

“…Abstract Platinum-based chemotherapy is the standard treatment for patients with advanced non-small cell lung cancer (NSCLC), but the evidence of its efficacy…”
Get full text

Bone Metastases from Gastric Cancer: What We Know and How to Deal with Them by Petrillo, Angelica, Giunta, Emilio Francesco, Pappalardo, Annalisa, Bosso, Davide, Attademo, Laura, Cardalesi, Cinzia, Diana, Anna, Fabbrocini, Antonietta, Fabozzi, Teresa, Giordano, Pasqualina, Ottaviano, Margaret, Rosanova, Mario, Silvestri, Antonia, Federico, Piera, Daniele, Bruno

“…Gastric cancer (GC) is the third cause of cancer-related death worldwide; the prognosis is poor especially in the case of metastatic disease. Liver, lymph…”
Get full text

The role of radiation therapy and systemic therapies in elderly with breast cancer by Nardone, Valerio, Falivene, Sara, Giugliano, Francesca Maria, Gaetano, Marcella, Giordano, Pasqualina, Muto, Matteo, Daniele, Bruno, Guida, Cesare

“…The focus of this review deals with the management of elderly patients with early stage breast cancer, discussing the role of systemic therapies [endocrine…”
Get full text

Multicenter Single-Arm, Two-Stage Phase 2 Study of Panitumumab in Patients With Cetuximab-Refractory Metastatic Colorectal Cancer: The PACER Trial by Piccirillo, Maria Carmela, Avallone, Antonio, Carlomagno, Chiara, Maiello, Evaristo, Rosati, Gerardo, Alabiso, Oscar, Nasti, Guglielmo, De Placido, Sabino, Latiano, Tizana Pia, Bilancia, Domenico, Ottaiano, Alessandro, De Stefano, Alfonso, Romano, Carmela, Silvestro, Lucrezia, Nappi, Anna, Cassata, Antonino, Giordano, Pasqualina, Iaffaioli, Rosario Vincenzo, Normanno, Nicola, Perrone, Francesco, Daniele, Bruno

“…To assess whether panitumumab is active in patients with cetuximab-refractory metastatic colorectal cancer (mCRC). Eligible patients had pretreated RAS…”
Get full text

How can we improve prognostic models in renal cell carcinoma? by Buonerba, Carlo, Ferro, Matteo, Perri, Francesco, Calderoni, Giuseppe, Mambella, Pina, Giordano, Pasqualina, Piscitelli, Prisco, Montanaro, Vittorino, Aieta, Michele, Di Lorenzo, Giuseppe

“…The therapeutic improvements in renal cell carcinoma brought about by the transition from the 'cytokine era' to the 'targeted agents era', have not affected…”
Get more information

New biological treatments for gynecological tumors: focus on angiogenesis by Daniele, Gennaro, Di Maio, Massimo, Piccirillo, Maria Carmela, Giordano, Pasqualina, Capuano, Ida, Cecere, Sabrina Chiara, Bryce, Jane Claire, Pignata, Sandro, Perrone, Francesco

“…Gynecological tumors are a group of heterogeneous malignancies, with only modest results having been observed thus far with chemotherapy in advanced disease…”
Get more information

Cetuximab in non-small-cell lung cancer by Carillio, Guido, Montanino, Agnese, Costanzo, Raffaele, Sandomenico, Claudia, Piccirillo, Maria Carmela, Di Maio, Massimo, Daniele, Gennaro, Giordano, Pasqualina, Bryce, Jane, Normanno, Nicola, Rocco, Gaetano, Perrone, Francesco, Morabito, Alessandro

“…Cetuximab is a chimeric human-mouse anti-EGF receptor monoclonal antibody. In Phase I studies, no dose-limiting toxicities were observed with cetuximab as a…”
Get full text